Clinical Trials
2 trialsNCT05958121 2025-11-18
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
Immatics Biotechnologies GmbH
Phase 1/2 Recruiting
NCT01572519 2020-11-20
A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1 Completed